Verition Fund Management’s ClearPoint Neuro CLPT Stock Holding History

Verition Fund Management’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,406	Closed	-$142K	–	2492
2025 Q4	$142K	Buy	+10,406	New	+$193K	﹤0.01%	3260
2024 Q4	–	Sell	-11,000	Closed	-$123K	–	3273
2024 Q3	$123K	Buy	+11,000	New	+$105K	﹤0.01%	2972
2023 Q3	–	Sell	-11,302	Closed	-$81.8K	–	2388
2023 Q2	$81.8K	Buy	+11,302	New	+$96.1K	﹤0.01%	1999

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Verition Fund Management's CLPT Position: Q1 2026 in Review

Verition Fund Management sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 10,406 shares — an estimated $142K sold.

Verition Fund Management first reported a position in CLPT in Q2 2023 and held it in 3 quarters. The position peaked at $142K in Q4 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Verition Fund Management reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
Verition Fund Management sold 10,406 ClearPoint Neuro shares in Q1 2026, an estimated $142K.
Verition Fund Management first reported a position in ClearPoint Neuro in Q2 2023 and held it in 3 quarters.
Verition Fund Management's ClearPoint Neuro position peaked at $142K in Q4 2025.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.